SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,000 | 0.0% | 8,816 | -23.8% | 0.00% | – |
| Q1 2016 | $3,000 | -78.6% | 11,573 | -69.8% | 0.00% | – |
| Q4 2015 | $14,000 | -81.1% | 38,298 | -10.9% | 0.00% | – |
| Q3 2015 | $74,000 | -38.8% | 42,986 | -20.8% | 0.00% | – |
| Q2 2015 | $121,000 | -67.4% | 54,305 | -71.7% | 0.00% | – |
| Q1 2015 | $371,000 | -77.8% | 191,827 | -69.6% | 0.00% | -100.0% |
| Q4 2014 | $1,670,000 | +81.7% | 630,445 | +106.3% | 0.00% | – |
| Q3 2014 | $919,000 | +99.8% | 305,601 | +172.1% | 0.00% | – |
| Q2 2014 | $460,000 | +27.4% | 112,330 | +34.4% | 0.00% | – |
| Q1 2014 | $361,000 | +7.1% | 83,582 | +30.0% | 0.00% | – |
| Q4 2013 | $337,000 | +23.9% | 64,286 | +49.6% | 0.00% | – |
| Q3 2013 | $272,000 | -64.2% | 42,982 | -71.8% | 0.00% | – |
| Q2 2013 | $760,000 | – | 152,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |